Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. (Q53754348)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. |
scientific article |
Statements
Chromogenic in situ hybridization is a reliable method for detecting HER2 gene status in breast cancer: a multicenter study using conventional scoring criteria and the new ASCO/CAP recommendations. (English)
1 reference
Yun Gong
1 reference
William Sweet
1 reference
Yi-Jing Duh
1 reference
Larry Greenfield
1 reference
Yuan Fang
1 reference
Jianxin Zhao
1 reference
Emily Tarco
1 reference
W Fraser Symmans
1 reference
Jorma Isola
1 reference
Nour Sneige
1 reference
1 April 2009
1 reference
131
1 reference
4
1 reference
490-497
1 reference
Identifiers
1 reference